Immunotec Inc (IMM.V) Quote| Reuters.com
Edition:
United States

Immunotec Inc (IMM.V)

IMM.V on TSX Venture Exchange

0.35CAD
23 Jun 2016
Change (% chg)

-- (--)
Prev Close
$0.35
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
13,589
52-wk High
$0.40
52-wk Low
$0.22

IMM.V

Chart for IMM.V

About

Immunotec Inc. is a Canada-based company that develops, manufactures, markets and sells research-driven nutritional products through direct-to-consumer sales channels in Canada, the United States and Mexico. The Company also subcontracts certain distribution logistics and manufacturing capacity activities in the United States,... (more)
No analyst recommendations are available for IMM.V.

Overall

Beta: -0.24
Market Cap(Mil.): $24.77
Shares Outstanding(Mil.): 69.76
Dividend: --
Yield (%): --

Financials

  IMM.V Industry Sector
P/E (TTM): 6.53 32.69 34.11
EPS (TTM): 0.05 -- --
ROI: 24.23 15.00 14.23
ROE: 27.86 16.08 15.46

BRIEF-Immunotec Inc posts qtrly rev C$25.6 mln vs C$20 mln last year

* Immunotec Inc qtrly revenues C$25.6 million versus C$20.00 million last year Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Jun 16 2016

BRIEF-Immunotec nominates Mario Paradis to its board of directors

* Immunotec announces the nomination of Mario Paradis to its board of directors and reports AGM results Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Apr 28 2016

BRIEF-Immunotec reports qtrly rev of c$22.9 mln versus c$17.9 mln

* Says network sales for three-month period ended january 31, 2016 reached $21.1 million compared to $16.3 million

Mar 30 2016

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.